_id string | corpus string | question string | answer string | question_language string | context_language string | mode string | persona string | generator_model_id string | generator_model_name string | candidate_id string | source_unit_id string | source_document_id string | generation_target_id string | evidence string | evidence_language string | supporting_text string | supporting_text_origin string | support_match_status string | document_text string | document_title string | generation_source_text string | generation_support_match_status string | articles_involved_raw string | grading_status string | quality_audit_status string | faithfulness_verifier_model string | quality_verifier_model string | persona_metadata_json string | metadata_json string | provenance_json string | is_best bool | answer_is_translation bool | evidence_is_translation bool | multi_article bool | multi_article_declared bool | multi_article_conflict bool | cross_act bool | cross_act_declared bool | multi_source_unit bool | candidate_rank int64 | support_start int64 | support_end int64 | num_involved_articles int64 | involved_article_ids list | involved_source_unit_ids list | unresolved_article_references list | faith_overall float64 | qual_overall float64 | total_score float64 | evidence_all_languages dict | evidence_alignment_status dict | evidence_alignment_eligibility string | evidence_alignment_contract string | evidence_en list | evidence_de list | evidence_es list | evidence_fr list | evidence_zh list |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
q_457b2ead5d495d1a66d560afc793125f19782c4f9358f2befc6f7ef1b3d68326 | chemistry | ¿Qué función se atribuye preferentemente a las amidina-amidas de naftaleno descritas en aplicaciones cosméticas? | Los compuestos son utiles para diferentes propositos, preferentemente como absorbentes de UV para aplicaciones cosmeticas. | es | es | conceptual | conceptual | gpt-5.6-luna | MX-2008001188-A_es | MX-2008001188-A_es | MX-2008001188-A_es | Los compuestos son utiles para diferentes propositos, preferentemente como absorbentes de UV para aplicaciones cosmeticas. | es | Los compuestos son utiles para diferentes propositos, preferentemente como absorbentes de UV para aplicaciones cosmeticas. | evidence | exact | Se describen amidina-amidas de naftaleno de la formula (ver formula) en donde R1, R2, R3, R4, R5 y R6 independientemente entre si son hidrogeno, o C1-C37alquilo; en donde uno a 10 de las unidades de CH2 del C1-C37alquilo independientemente entre si se puede sustituir por grupos carbonilo; atomos de oxigeno, atomos de a... | Se describen amidina-amidas de naftaleno de la formula (ver formula) en donde R1, R2, R3, R4, R5 y R6 independientemente entre si son hidrogeno, o C1-C37alquilo; en donde uno a 10 de las unidades de CH2 del C1-C37alquilo independientemente entre si se puede sustituir por grupos carbonilo; atomos de oxigeno, atomos de a... | exact | clear | {"anchor": "amidina-amidas de naftaleno descritas", "assertion": "", "assertion_status": "", "comparison_aspect": "", "comparison_entities": "", "constraints": "", "decider_confidence": "0.68", "decider_counts_before_json": "{\"assertion_verification\": 1, \"comparison\": 1, \"conceptual\": 0, \"constraint_search\": 0,... | {"anchor": "amidina-amidas de naftaleno descritas", "answer": "Los compuestos son utiles para diferentes propositos, preferentemente como absorbentes de UV para aplicaciones cosmeticas.", "answer_is_translation": "false", "assertion": "", "assertion_status": "", "candidate_id": "", "candidate_rank": "1", "comparison_as... | {"file": "data/chemistry/ai4chem_abstract_pairs/qac/chemistry_google_patents_model_comparison_generator/generator_compare_200_gpt-5.6-luna_gemini38.csv", "line": 2, "model": "gpt-5.6-luna"} | null | false | null | false | null | false | false | null | false | 1 | 3,556 | 3,678 | 0 | [] | [
"MX-2008001188-A_es"
] | [] | 12 | 20 | 32 | {
"en": [
{
"source_unit_id": "MX-2008001188-A_en",
"language": null,
"text": "The compounds are useful for different purposes, preferably as UV absorbers for cosmetic applications.",
"anchor_id": "a_bae1242ef56099dbbafb7e795322bb4cbf5104c07606570f910e812fc547d009",
"origin": "cross_... | {
"en": [
{
"source_unit_id": "MX-2008001188-A_en",
"anchor_id": "a_bae1242ef56099dbbafb7e795322bb4cbf5104c07606570f910e812fc547d009",
"status": "matched",
"alignment_id": "t_bc47f1eac1d12acdc0c7e5abfe75dd242dd9d103b0af00b74498d27098723ab1:a_bae1242ef56099dbbafb7e795322bb4cbf5104c07606570f... | eligible | cross_language_evidence_terra_v1 | [
"The compounds are useful for different purposes, preferably as UV absorbers for cosmetic applications."
] | [] | [
"Los compuestos son utiles para diferentes propositos, preferentemente como absorbentes de UV para aplicaciones cosmeticas."
] | [] | [] | |||||||
q_4158552ba9bc172e36cf4cd7ef5a4fd59b89794020c07eb1e596df0d5d457f99 | chemistry | ¿Qué método permite sintetizar materiales zeolíticos de poro grande relacionados estructuralmente con la zeolita Beta? | El método consiste en el calentamiento a 363-473K de una mezcla de reacción que contiene una fuente de al menos un elemento tetravalente T(IV), opcionalmente una fuente de un elemento T(III), opcionalmente H¿2?O2, un catión orgánico director de estructura, una fuente de aniones F?-¿ y agua, no siendo necesaria la prese... | es | es | process_retrieval | process_retrieval | gpt-5.6-luna | WO-9940026-A1_es | WO-9940026-A1_es | WO-9940026-A1_es | El método consiste en el calentamiento a 363-473K de una mezcla de reacción que contiene una fuente de al menos un elemento tetravalente T(IV), opcionalmente una fuente de un elemento T(III), opcionalmente H¿2?O2, un catión orgánico director de estructura, una fuente de aniones F?-¿ y agua, no siendo necesaria la prese... | es | El método consiste en el calentamiento a 363-473K de una mezcla de reacción que contiene una fuente de al menos un elemento tetravalente T(IV), opcionalmente una fuente de un elemento T(III), opcionalmente H¿2?O2, un catión orgánico director de estructura, una fuente de aniones F?-¿ y agua, no siendo necesaria la prese... | evidence | exact | En la presente invención se reivindican métodos de síntesis de materiales zeolíticos de poro grande relacionados estructuralmente con la zeolita Beta, caracterizados por el relativamente bajo pH del medio de síntesis y la utilización de aniones F- como mineralizante, y a los materiales obtenidos, caracterizados por su ... | En la presente invención se reivindican métodos de síntesis de materiales zeolíticos de poro grande relacionados estructuralmente con la zeolita Beta, caracterizados por el relativamente bajo pH del medio de síntesis y la utilización de aniones F- como mineralizante, y a los materiales obtenidos, caracterizados por su ... | exact | repair | {"anchor": "materiales zeolíticos de poro grande relacionados estructuralmente con la zeolita Beta", "assertion": "", "assertion_status": "", "comparison_aspect": "", "comparison_entities": "", "constraints": "", "decider_confidence": "0.8", "decider_counts_before_json": "{\"assertion_verification\": 0, \"comparison\":... | {"anchor": "materiales zeolíticos de poro grande relacionados estructuralmente con la zeolita Beta", "answer": "El método consiste en el calentamiento a 363-473K de una mezcla de reacción que contiene una fuente de al menos un elemento tetravalente T(IV), opcionalmente una fuente de un elemento T(III), opcionalmente H¿... | {"file": "data/chemistry/ai4chem_abstract_pairs/qac/chemistry_google_patents_model_comparison_generator/generator_compare_200_gpt-5.6-luna_gemini38.csv", "line": 3, "model": "gpt-5.6-luna"} | null | false | null | false | null | false | false | null | false | 1 | 803 | 1,150 | 0 | [] | [
"WO-9940026-A1_es"
] | [] | 12 | 18 | 30 | {
"en": [],
"de": [],
"es": [
{
"source_unit_id": "WO-9940026-A1_es",
"language": "es",
"text": "El método consiste en el calentamiento a 363-473K de una mezcla de reacción que contiene una fuente de al menos un elemento tetravalente T(IV), opcionalmente una fuente de un elemento T(III), opc... | {
"en": [],
"de": [],
"es": [
{
"source_unit_id": "WO-9940026-A1_es",
"anchor_id": "a_5c677d5b766371b0dc85c2a976edf33dac2bfdcb754bdac74156e7fb9d99ee5a",
"status": "source_exact",
"alignment_id": null,
"task_id": null,
"request_hash": null,
"validation_status": null,
... | eligible | cross_language_evidence_terra_v1 | [] | [] | [
"El método consiste en el calentamiento a 363-473K de una mezcla de reacción que contiene una fuente de al menos un elemento tetravalente T(IV), opcionalmente una fuente de un elemento T(III), opcionalmente H¿2?O2, un catión orgánico director de estructura, una fuente de aniones F?-¿ y agua, no siendo necesaria la ... | [
"Le procédé consiste à chauffer à une température allant de 363 à 473K un mélange réactionnel contenant une source d'au moins un élément tétravalent (T(IV), éventuellement une source d'un élément T(III), éventuellement H¿2?O2, un cation organique structurant, une source d'anions F?-¿ et de l'eau, la présence de cat... | [] | |||||||
q_851753b284960b6549f9dc5c4cf2602947f061dfe994c42d21acd8ed27b13931 | chemistry | 哪份专利公开文本描述了包含至少一种式I的取代3-羟基甲基吡啶化合物或其盐,以及至少一种其它杀真菌活性化合物II的杀真菌活性化合物混合物,其中式I中的X为O、S或NR4? | CN-101909442-A | zh | zh | source_finding | source_finding | gpt-5.6-luna | CN-101909442-A_zh | CN-101909442-A_zh | CN-101909442-A_zh | 本发明涉及包含至少一种式I的取代的3-羟基甲基吡啶化合物或其盐和至少一种其它杀真菌活性化合物II的杀真菌活性化合物的混合物。其中X为O、S或NR 4 ;R 1 为C 1 -C 6 烷基、C 1 -C 6 烷氧基-C 1 -C 6 烷基、C 1 -C 6 卤代烷基、芳基-C 1 -C 4 烷基、芳氧基-C 1 -C 4 烷基、芳硫基-C 1 -C 4 烷基、芳基或杂芳基,其中后5个基团的环状结构部分未被取代或被1、2或3个选自如下的基团取代:卤素、C 1 -C 4 烷基、C 2 -C 4 链烯基、C 2 -C 4 炔基、C 1 -C 4 卤代烷基、C 1 -C 4 烷氧基、C 1 -C 4 烷硫基、C 1 -C 4 卤代烷氧基、C 1... | zh | 本发明涉及包含至少一种式I的取代的3-羟基甲基吡啶化合物或其盐和至少一种其它杀真菌活性化合物II的杀真菌活性化合物的混合物。其中X为O、S或NR 4 ;R 1 为C 1 -C 6 烷基、C 1 -C 6 烷氧基-C 1 -C 6 烷基、C 1 -C 6 卤代烷基、芳基-C 1 -C 4 烷基、芳氧基-C 1 -C 4 烷基、芳硫基-C 1 -C 4 烷基、芳基或杂芳基,其中后5个基团的环状结构部分未被取代或被1、2或3个选自如下的基团取代:卤素、C 1 -C 4 烷基、C 2 -C 4 链烯基、C 2 -C 4 炔基、C 1 -C 4 卤代烷基、C 1 -C 4 烷氧基、C 1 -C 4 烷硫基、C 1 -C 4 卤代烷氧基、C 1... | evidence | exact | 本发明涉及包含至少一种式I的取代的3-羟基甲基吡啶化合物或其盐和至少一种其它杀真菌活性化合物II的杀真菌活性化合物的混合物。其中X为O、S或NR 4 ;R 1 为C 1 -C 6 烷基、C 1 -C 6 烷氧基-C 1 -C 6 烷基、C 1 -C 6 卤代烷基、芳基-C 1 -C 4 烷基、芳氧基-C 1 -C 4 烷基、芳硫基-C 1 -C 4 烷基、芳基或杂芳基,其中后5个基团的环状结构部分未被取代或被1、2或3个选自如下的基团取代:卤素、C 1 -C 4 烷基、C 2 -C 4 链烯基、C 2 -C 4 炔基、C 1 -C 4 卤代烷基、C 1 -C 4 烷氧基、C 1 -C 4 烷硫基、C 1 -C 4 卤代烷氧基、C 1... | 本发明涉及包含至少一种式I的取代的3-羟基甲基吡啶化合物或其盐和至少一种其它杀真菌活性化合物II的杀真菌活性化合物的混合物。其中X为O、S或NR 4 ;R 1 为C 1 -C 6 烷基、C 1 -C 6 烷氧基-C 1 -C 6 烷基、C 1 -C 6 卤代烷基、芳基-C 1 -C 4 烷基、芳氧基-C 1 -C 4 烷基、芳硫基-C 1 -C 4 烷基、芳基或杂芳基,其中后5个基团的环状结构部分未被取代或被1、2或3个选自如下的基团取代:卤素、C 1 -C 4 烷基、C 2 -C 4 链烯基、C 2 -C 4 炔基、C 1 -C 4 卤代烷基、C 1 -C 4 烷氧基、C 1 -C 4 烷硫基、C 1 -C 4 卤代烷氧基、C 1... | exact | clear | {"anchor": "包含至少一种式I的取代3-羟基甲基吡啶化合物或其盐,以及至少一种其它杀真菌活性化合物II的杀真菌活性化合物混合物", "assertion": "", "assertion_status": "", "comparison_aspect": "", "comparison_entities": "", "constraints": "", "decider_confidence": "0.66", "decider_counts_before_json": "{\"assertion_verification\": 0, \"comparison\": 1, \"conceptual\": 0, \"cons... | {"anchor": "包含至少一种式I的取代3-羟基甲基吡啶化合物或其盐,以及至少一种其它杀真菌活性化合物II的杀真菌活性化合物混合物", "answer": "CN-101909442-A", "answer_is_translation": "false", "assertion": "", "assertion_status": "", "candidate_id": "", "candidate_rank": "1", "comparison_aspect": "", "comparison_entities": "", "constraints": "", "context_language": "zh", "conte... | {"file": "data/chemistry/ai4chem_abstract_pairs/qac/chemistry_google_patents_model_comparison_generator/generator_compare_200_gpt-5.6-luna_gemini38.csv", "line": 4, "model": "gpt-5.6-luna"} | null | false | null | false | null | false | false | null | false | 1 | 0 | 883 | 0 | [] | [
"CN-101909442-A_zh"
] | [] | 11 | 20 | 31 | {
"en": [
{
"source_unit_id": "CN-101909442-A_en",
"language": null,
"text": "The present invention relates to mixtures of fungicidally active compounds comprising at least one substituted 3-hydroxymethylpyridine compound of formula I or a salt thereof and at least one further fungicidally activ... | {
"en": [
{
"source_unit_id": "CN-101909442-A_en",
"anchor_id": "a_b070e0fbc0bf9ed27b2883e98a8865b0867bbaf96762e292377be519c792a712",
"status": "matched",
"alignment_id": "t_489b87af654322f63a389a6f0f4b4cb8e1e4131c8d64bb89d007a9dd751cd208:a_b070e0fbc0bf9ed27b2883e98a8865b0867bbaf96762e2923... | eligible | cross_language_evidence_terra_v1 | [
"The present invention relates to mixtures of fungicidally active compounds comprising at least one substituted 3-hydroxymethylpyridine compound of formula I or a salt thereof and at least one further fungicidally active compound II. Wherein X is O, S or NR 4 ;R 1 Is C 1 -C 6 Alkyl radical, C 1 -C 6 alkoxy-C 1 -C 6... | [] | [] | [] | [
"本发明涉及包含至少一种式I的取代的3-羟基甲基吡啶化合物或其盐和至少一种其它杀真菌活性化合物II的杀真菌活性化合物的混合物。其中X为O、S或NR 4 ;R 1 为C 1 -C 6 烷基、C 1 -C 6 烷氧基-C 1 -C 6 烷基、C 1 -C 6 卤代烷基、芳基-C 1 -C 4 烷基、芳氧基-C 1 -C 4 烷基、芳硫基-C 1 -C 4 烷基、芳基或杂芳基,其中后5个基团的环状结构部分未被取代或被1、2或3个选自如下的基团取代:卤素、C 1 -C 4 烷基、C 2 -C 4 链烯基、C 2 -C 4 炔基、C 1 -C 4 卤代烷基、C 1 -C 4 烷氧基、C 1 -C 4 烷硫基、C 1 -C 4 卤代烷氧... | |||||||
q_4b397b7324634cd3a66acd8569182fa2ef2a08b33240952e25f7e6699803aed8 | chemistry | Welche gemeinsamen zulässigen Substituentenoptionen sind für R 1 und R 3 der Formel I bei den neuen Nitroenamin-Derivaten angegeben? | Neue Nitroenamin-Derivate der Formel I worin R 1 Wasserstoff, C 1 -C 6 -Alkyl oder C 3 -C 6 -Cycloalkyl, R 2 Wasserstoff oder C 1 -C 6 -Alkyl, R 3 Wasserstoff, C 1 -C 6 -Alkyl oder C 3 -C 6 -Cydoalkyl, R 4 Wasserstoff, C 1 -C 6 -Alkyl, C 3 -C 6 -Cycloalkyl oder einen Rest -CH 2 -B | de | de | comparison | comparison | gpt-5.6-luna | EP-0453398-A2_de | EP-0453398-A2_de | EP-0453398-A2_de | Neue Nitroenamin-Derivate der Formel I worin R 1 Wasserstoff, C 1 -C 6 -Alkyl oder C 3 -C 6 -Cycloalkyl, R 2 Wasserstoff oder C 1 -C 6 -Alkyl, R 3 Wasserstoff, C 1 -C 6 -Alkyl oder C 3 -C 6 -Cydoalkyl, R 4 Wasserstoff, C 1 -C 6 -Alkyl, C 3 -C 6 -Cycloalkyl oder einen Rest -CH 2 -B | de | Neue Nitroenamin-Derivate der Formel I worin R 1 Wasserstoff, C 1 -C 6 -Alkyl oder C 3 -C 6 -Cycloalkyl, R 2 Wasserstoff oder C 1 -C 6 -Alkyl, R 3 Wasserstoff, C 1 -C 6 -Alkyl oder C 3 -C 6 -Cydoalkyl, R 4 Wasserstoff, C 1 -C 6 -Alkyl, C 3 -C 6 -Cycloalkyl oder einen Rest -CH 2 -B | evidence | exact | Neue Nitroenamin-Derivate der Formel I worin R 1 Wasserstoff, C 1 -C 6 -Alkyl oder C 3 -C 6 -Cycloalkyl, R 2 Wasserstoff oder C 1 -C 6 -Alkyl, R 3 Wasserstoff, C 1 -C 6 -Alkyl oder C 3 -C 6 -Cydoalkyl, R 4 Wasserstoff, C 1 -C 6 -Alkyl, C 3 -C 6 -Cycloalkyl oder einen Rest -CH 2 -B, oder R 3 und R 4 gemeinsam -(CH 2 ) 4... | Neue Nitroenamin-Derivate der Formel I worin R 1 Wasserstoff, C 1 -C 6 -Alkyl oder C 3 -C 6 -Cycloalkyl, R 2 Wasserstoff oder C 1 -C 6 -Alkyl, R 3 Wasserstoff, C 1 -C 6 -Alkyl oder C 3 -C 6 -Cydoalkyl, R 4 Wasserstoff, C 1 -C 6 -Alkyl, C 3 -C 6 -Cycloalkyl oder einen Rest -CH 2 -B, oder R 3 und R 4 gemeinsam -(CH 2 ) 4... | exact | clear | {"anchor": "neuen Nitroenamin-Derivaten", "assertion": "", "assertion_status": "", "comparison_aspect": "zulässige Substituentenoptionen", "comparison_entities": "[\"R 1\", \"R 3\"]", "constraints": "", "decider_confidence": "0.78", "decider_counts_before_json": "{\"assertion_verification\": 0, \"comparison\": 0, \"con... | {"anchor": "neuen Nitroenamin-Derivaten", "answer": "Neue Nitroenamin-Derivate der Formel I worin R 1 Wasserstoff, C 1 -C 6 -Alkyl oder C 3 -C 6 -Cycloalkyl, R 2 Wasserstoff oder C 1 -C 6 -Alkyl, R 3 Wasserstoff, C 1 -C 6 -Alkyl oder C 3 -C 6 -Cydoalkyl, R 4 Wasserstoff, C 1 -C 6 -Alkyl, C 3 -C 6 -Cycloalkyl oder einen... | {"file": "data/chemistry/ai4chem_abstract_pairs/qac/chemistry_google_patents_model_comparison_generator/generator_compare_200_gpt-5.6-luna_gemini38.csv", "line": 5, "model": "gpt-5.6-luna"} | null | false | null | false | null | false | false | null | false | 1 | 0 | 281 | 0 | [] | [
"EP-0453398-A2_de"
] | [] | 11 | 19 | 30 | {
"en": [
{
"source_unit_id": "EP-0453398-A2_en",
"language": null,
"text": "R1 is hydrogen, C1-C6-alkyl or C3-C6-cycloalkyl, R2 is hydrogen or C1-C6-alkyl, R3 is hydrogen, C1-C6-alkyl or C3-C6-cycloalkyl",
"anchor_id": "a_0345d2309f0238d9d6b3d35a869c3aa1ecb695d30544404a613946a759deb2f6",
... | {
"en": [
{
"source_unit_id": "EP-0453398-A2_en",
"anchor_id": "a_0345d2309f0238d9d6b3d35a869c3aa1ecb695d30544404a613946a759deb2f6",
"status": "matched",
"alignment_id": "t_f0fcf8abd093aa7c104c1e5caa60e4f4102280c5b38eef95bf0d82438d4b2b7b:a_0345d2309f0238d9d6b3d35a869c3aa1ecb695d30544404a61... | eligible | cross_language_evidence_terra_v1 | [
"R1 is hydrogen, C1-C6-alkyl or C3-C6-cycloalkyl, R2 is hydrogen or C1-C6-alkyl, R3 is hydrogen, C1-C6-alkyl or C3-C6-cycloalkyl"
] | [
"Neue Nitroenamin-Derivate der Formel I worin R 1 Wasserstoff, C 1 -C 6 -Alkyl oder C 3 -C 6 -Cycloalkyl, R 2 Wasserstoff oder C 1 -C 6 -Alkyl, R 3 Wasserstoff, C 1 -C 6 -Alkyl oder C 3 -C 6 -Cydoalkyl, R 4 Wasserstoff, C 1 -C 6 -Alkyl, C 3 -C 6 -Cycloalkyl oder einen Rest -CH 2 -B"
] | [] | [] | [] | |||||||
q_1089f9e3f3ace9615b72aeceb2b45f033943c59d8c22ea93e3869c56c3db523d | chemistry | 在黄褐斑鼠模型中,CLY系列化合物对皮肤和血中酪氨酸酶水平、皮肤中SCF和C-kit蛋白表达及黄褐斑色素形成有何影响? | 动物模型实验表明,化合物CLY系列均能明显减少黄褐斑鼠模型皮肤和血中的酪氨酸酶水平,减少皮肤中肝细胞因子(SCF)、C-kit蛋白表达,抑制黄褐斑的色素形成 | zh | zh | lookup | lookup | gpt-5.6-luna | WO-2022262854-A1_zh | WO-2022262854-A1_zh | WO-2022262854-A1_zh | 动物模型实验表明,化合物CLY系列均能明显减少黄褐斑鼠模型皮肤和血中的酪氨酸酶水平,减少皮肤中肝细胞因子(SCF)、C-kit蛋白表达,抑制黄褐斑的色素形成 | zh | 动物模型实验表明,化合物CLY系列均能明显减少黄褐斑鼠模型皮肤和血中的酪氨酸酶水平,减少皮肤中肝细胞因子(SCF)、C-kit蛋白表达,抑制黄褐斑的色素形成 | evidence | exact | 本发明公开一种CLY系列化合物及其制备方法和制备药物的用途,所述CLY系列化合物为具有式I结构的化合物,其互变异构体,其溶剂化物或其药学上可接受的盐,动物模型实验表明,化合物CLY系列均能明显减少黄褐斑鼠模型皮肤和血中的酪氨酸酶水平,减少皮肤中肝细胞因子(SCF)、C-kit蛋白表达,抑制黄褐斑的色素形成;能明显促进皮肤创面愈合,减少疤痕形成;能够明显促进脱发鼠模型的毛发生长,减少对毛囊的破坏;能明显减轻兔耳痤疮模型症状,减少毛孔堵塞和粉刺形成;CLY系列化合物能明显提高急性GVHD小鼠生存时间,减轻临床症状,显示对急性GVHD具有治疗作用;能明显降低肺纤维化小鼠模型肺组织中MMP-2、MMP-9水平,增加TIMP-1和VEGF水平... | 本发明公开一种CLY系列化合物及其制备方法和制备药物的用途,所述CLY系列化合物为具有式I结构的化合物,其互变异构体,其溶剂化物或其药学上可接受的盐,动物模型实验表明,化合物CLY系列均能明显减少黄褐斑鼠模型皮肤和血中的酪氨酸酶水平,减少皮肤中肝细胞因子(SCF)、C-kit蛋白表达,抑制黄褐斑的色素形成;能明显促进皮肤创面愈合,减少疤痕形成;能够明显促进脱发鼠模型的毛发生长,减少对毛囊的破坏;能明显减轻兔耳痤疮模型症状,减少毛孔堵塞和粉刺形成;CLY系列化合物能明显提高急性GVHD小鼠生存时间,减轻临床症状,显示对急性GVHD具有治疗作用;能明显降低肺纤维化小鼠模型肺组织中MMP-2、MMP-9水平,增加TIMP-1和VEGF水平... | exact | clear | {"anchor": "黄褐斑鼠模型", "assertion": "", "assertion_status": "", "comparison_aspect": "", "comparison_entities": "", "constraints": "", "decider_confidence": "0.76", "decider_counts_before_json": "{\"assertion_verification\": 0, \"comparison\": 0, \"conceptual\": 0, \"constraint_search\": 0, \"lookup\": 0, \"process_retri... | {"anchor": "黄褐斑鼠模型", "answer": "动物模型实验表明,化合物CLY系列均能明显减少黄褐斑鼠模型皮肤和血中的酪氨酸酶水平,减少皮肤中肝细胞因子(SCF)、C-kit蛋白表达,抑制黄褐斑的色素形成", "answer_is_translation": "false", "assertion": "", "assertion_status": "", "candidate_id": "", "candidate_rank": "1", "comparison_aspect": "", "comparison_entities": "", "constraints": "", "context_language"... | {"file": "data/chemistry/ai4chem_abstract_pairs/qac/chemistry_google_patents_model_comparison_generator/generator_compare_200_gpt-5.6-luna_gemini38.csv", "line": 6, "model": "gpt-5.6-luna"} | null | false | null | false | null | false | false | null | false | 1 | 75 | 153 | 0 | [] | [
"WO-2022262854-A1_zh"
] | [] | 12 | 20 | 32 | {
"en": [],
"de": [],
"es": [],
"fr": [
{
"source_unit_id": "WO-2022262854-A1_fr",
"language": null,
"text": "le composé série CLY, dans un modèle de souris à chloasma, peut évidemment réduire le niveau de tyrosinase dans la peau et le sang, réduire l'expression du facteur de cellules souc... | {
"en": [],
"de": [],
"es": [],
"fr": [
{
"source_unit_id": "WO-2022262854-A1_fr",
"anchor_id": "a_4acd57ecbc95f37731ff1596798936d1c553e4592b497a257ac8ce914b141d54",
"status": "matched",
"alignment_id": "t_947cbef816b817acc6da3015847ee8fda863bd06081ccf81b5b4ff6d4ee223a0:a_4acd57ecbc9... | eligible | cross_language_evidence_terra_v1 | [] | [] | [] | [
"le composé série CLY, dans un modèle de souris à chloasma, peut évidemment réduire le niveau de tyrosinase dans la peau et le sang, réduire l'expression du facteur de cellules souches (SCF) et une protéine C-Kit dans la peau, et inhibent la chromogenèse du chloasma"
] | [
"动物模型实验表明,化合物CLY系列均能明显减少黄褐斑鼠模型皮肤和血中的酪氨酸酶水平,减少皮肤中肝细胞因子(SCF)、C-kit蛋白表达,抑制黄褐斑的色素形成"
] | |||||||
q_c07a4a959499f3d2e2683908675a7f67292cefc6337a8fc683e97bb6567209af | chemistry | 在肺纤维化小鼠模型中,CLY系列化合物能如何改变肺组织中的MMP-2、MMP-9、TIMP-1和VEGF水平,以及外周血中的SOD和CAT酶水平? | 能明显降低肺纤维化小鼠模型肺组织中MMP-2、MMP-9水平,增加TIMP-1和VEGF水平,同时可提高外周血中SOD、CAT酶水平 | zh | zh | lookup | lookup | gpt-5.6-luna | WO-2022262854-A1_zh | WO-2022262854-A1_zh | WO-2022262854-A1_zh | 能明显降低肺纤维化小鼠模型肺组织中MMP-2、MMP-9水平,增加TIMP-1和VEGF水平,同时可提高外周血中SOD、CAT酶水平 | zh | 能明显降低肺纤维化小鼠模型肺组织中MMP-2、MMP-9水平,增加TIMP-1和VEGF水平,同时可提高外周血中SOD、CAT酶水平 | evidence | exact | 本发明公开一种CLY系列化合物及其制备方法和制备药物的用途,所述CLY系列化合物为具有式I结构的化合物,其互变异构体,其溶剂化物或其药学上可接受的盐,动物模型实验表明,化合物CLY系列均能明显减少黄褐斑鼠模型皮肤和血中的酪氨酸酶水平,减少皮肤中肝细胞因子(SCF)、C-kit蛋白表达,抑制黄褐斑的色素形成;能明显促进皮肤创面愈合,减少疤痕形成;能够明显促进脱发鼠模型的毛发生长,减少对毛囊的破坏;能明显减轻兔耳痤疮模型症状,减少毛孔堵塞和粉刺形成;CLY系列化合物能明显提高急性GVHD小鼠生存时间,减轻临床症状,显示对急性GVHD具有治疗作用;能明显降低肺纤维化小鼠模型肺组织中MMP-2、MMP-9水平,增加TIMP-1和VEGF水平... | 本发明公开一种CLY系列化合物及其制备方法和制备药物的用途,所述CLY系列化合物为具有式I结构的化合物,其互变异构体,其溶剂化物或其药学上可接受的盐,动物模型实验表明,化合物CLY系列均能明显减少黄褐斑鼠模型皮肤和血中的酪氨酸酶水平,减少皮肤中肝细胞因子(SCF)、C-kit蛋白表达,抑制黄褐斑的色素形成;能明显促进皮肤创面愈合,减少疤痕形成;能够明显促进脱发鼠模型的毛发生长,减少对毛囊的破坏;能明显减轻兔耳痤疮模型症状,减少毛孔堵塞和粉刺形成;CLY系列化合物能明显提高急性GVHD小鼠生存时间,减轻临床症状,显示对急性GVHD具有治疗作用;能明显降低肺纤维化小鼠模型肺组织中MMP-2、MMP-9水平,增加TIMP-1和VEGF水平... | exact | clear | {"anchor": "肺纤维化小鼠模型", "assertion": "", "assertion_status": "", "comparison_aspect": "", "comparison_entities": "", "constraints": "", "decider_confidence": "0.76", "decider_counts_before_json": "{\"assertion_verification\": 0, \"comparison\": 0, \"conceptual\": 0, \"constraint_search\": 0, \"lookup\": 0, \"process_ret... | {"anchor": "肺纤维化小鼠模型", "answer": "能明显降低肺纤维化小鼠模型肺组织中MMP-2、MMP-9水平,增加TIMP-1和VEGF水平,同时可提高外周血中SOD、CAT酶水平", "answer_is_translation": "false", "assertion": "", "assertion_status": "", "candidate_id": "", "candidate_rank": "2", "comparison_aspect": "", "comparison_entities": "", "constraints": "", "context_language": "zh", "c... | {"file": "data/chemistry/ai4chem_abstract_pairs/qac/chemistry_google_patents_model_comparison_generator/generator_compare_200_gpt-5.6-luna_gemini38.csv", "line": 7, "model": "gpt-5.6-luna"} | null | false | null | false | null | false | false | null | false | 2 | 274 | 340 | 0 | [] | [
"WO-2022262854-A1_zh"
] | [] | 12 | 20 | 32 | {
"en": [],
"de": [],
"es": [],
"fr": [
{
"source_unit_id": "WO-2022262854-A1_fr",
"language": null,
"text": "dans un modèle de souris à fibrose pulmonaire, il peut évidemment réduire les taux de MMP-2 et MMP-9 dans le tissu pulmonaire, augmenter les taux de TIMP-1 et VEGF, et augmenter si... | {
"en": [],
"de": [],
"es": [],
"fr": [
{
"source_unit_id": "WO-2022262854-A1_fr",
"anchor_id": "a_84d9cece33ac5802b00db4a0617671aeed2fcc8458a14a7b090f71451f97eaae",
"status": "matched",
"alignment_id": "t_947cbef816b817acc6da3015847ee8fda863bd06081ccf81b5b4ff6d4ee223a0:a_84d9cece33a... | eligible | cross_language_evidence_terra_v1 | [] | [] | [] | [
"dans un modèle de souris à fibrose pulmonaire, il peut évidemment réduire les taux de MMP-2 et MMP-9 dans le tissu pulmonaire, augmenter les taux de TIMP-1 et VEGF, et augmenter simultanément les taux d'enzymes SOD et CAT dans le sang périphérique"
] | [
"能明显降低肺纤维化小鼠模型肺组织中MMP-2、MMP-9水平,增加TIMP-1和VEGF水平,同时可提高外周血中SOD、CAT酶水平"
] | |||||||
q_8e66ce68207c4719bd1aa3ed8730dac5dd7df56e3b1ea066c6b24d009381ef9c | chemistry | 在急性GVHD小鼠模型中,CLY系列化合物对小鼠生存时间和临床症状有何影响?是否显示出对急性GVHD的治疗作用? | CLY系列化合物能明显提高急性GVHD小鼠生存时间,减轻临床症状,显示对急性GVHD具有治疗作用 | zh | zh | lookup | lookup | gpt-5.6-luna | WO-2022262854-A1_zh | WO-2022262854-A1_zh | WO-2022262854-A1_zh | CLY系列化合物能明显提高急性GVHD小鼠生存时间,减轻临床症状,显示对急性GVHD具有治疗作用 | zh | CLY系列化合物能明显提高急性GVHD小鼠生存时间,减轻临床症状,显示对急性GVHD具有治疗作用 | evidence | exact | 本发明公开一种CLY系列化合物及其制备方法和制备药物的用途,所述CLY系列化合物为具有式I结构的化合物,其互变异构体,其溶剂化物或其药学上可接受的盐,动物模型实验表明,化合物CLY系列均能明显减少黄褐斑鼠模型皮肤和血中的酪氨酸酶水平,减少皮肤中肝细胞因子(SCF)、C-kit蛋白表达,抑制黄褐斑的色素形成;能明显促进皮肤创面愈合,减少疤痕形成;能够明显促进脱发鼠模型的毛发生长,减少对毛囊的破坏;能明显减轻兔耳痤疮模型症状,减少毛孔堵塞和粉刺形成;CLY系列化合物能明显提高急性GVHD小鼠生存时间,减轻临床症状,显示对急性GVHD具有治疗作用;能明显降低肺纤维化小鼠模型肺组织中MMP-2、MMP-9水平,增加TIMP-1和VEGF水平... | 本发明公开一种CLY系列化合物及其制备方法和制备药物的用途,所述CLY系列化合物为具有式I结构的化合物,其互变异构体,其溶剂化物或其药学上可接受的盐,动物模型实验表明,化合物CLY系列均能明显减少黄褐斑鼠模型皮肤和血中的酪氨酸酶水平,减少皮肤中肝细胞因子(SCF)、C-kit蛋白表达,抑制黄褐斑的色素形成;能明显促进皮肤创面愈合,减少疤痕形成;能够明显促进脱发鼠模型的毛发生长,减少对毛囊的破坏;能明显减轻兔耳痤疮模型症状,减少毛孔堵塞和粉刺形成;CLY系列化合物能明显提高急性GVHD小鼠生存时间,减轻临床症状,显示对急性GVHD具有治疗作用;能明显降低肺纤维化小鼠模型肺组织中MMP-2、MMP-9水平,增加TIMP-1和VEGF水平... | exact | clear | {"anchor": "急性GVHD小鼠", "assertion": "", "assertion_status": "", "comparison_aspect": "", "comparison_entities": "", "constraints": "", "decider_confidence": "0.76", "decider_counts_before_json": "{\"assertion_verification\": 0, \"comparison\": 0, \"conceptual\": 0, \"constraint_search\": 0, \"lookup\": 0, \"process_ret... | {"anchor": "急性GVHD小鼠", "answer": "CLY系列化合物能明显提高急性GVHD小鼠生存时间,减轻临床症状,显示对急性GVHD具有治疗作用", "answer_is_translation": "false", "assertion": "", "assertion_status": "", "candidate_id": "", "candidate_rank": "3", "comparison_aspect": "", "comparison_entities": "", "constraints": "", "context_language": "zh", "context_languages":... | {"file": "data/chemistry/ai4chem_abstract_pairs/qac/chemistry_google_patents_model_comparison_generator/generator_compare_200_gpt-5.6-luna_gemini38.csv", "line": 8, "model": "gpt-5.6-luna"} | null | false | null | false | null | false | false | null | false | 3 | 225 | 273 | 0 | [] | [
"WO-2022262854-A1_zh"
] | [] | 12 | 19 | 31 | {
"en": [],
"de": [],
"es": [],
"fr": [
{
"source_unit_id": "WO-2022262854-A1_fr",
"language": null,
"text": "Le composé série CLY peut prolonger de manière significative le temps de survie de souris à GVH aiguë, et peut réduire les symptômes cliniques, présentant un effet thérapeutique su... | {
"en": [],
"de": [],
"es": [],
"fr": [
{
"source_unit_id": "WO-2022262854-A1_fr",
"anchor_id": "a_969801ee8359f903a39cacb4934eb7080dbc723a8a9dd32df91a75d0c21edbff",
"status": "matched",
"alignment_id": "t_947cbef816b817acc6da3015847ee8fda863bd06081ccf81b5b4ff6d4ee223a0:a_969801ee835... | eligible | cross_language_evidence_terra_v1 | [] | [] | [] | [
"Le composé série CLY peut prolonger de manière significative le temps de survie de souris à GVH aiguë, et peut réduire les symptômes cliniques, présentant un effet thérapeutique sur GVH aigu"
] | [
"CLY系列化合物能明显提高急性GVHD小鼠生存时间,减轻临床症状,显示对急性GVHD具有治疗作用"
] | |||||||
q_7612f250d4f1141b2de506bb3eaf24391b1e7e497bc9c4c562564df99218202a | chemistry | "¿Se ha divulgado un método para producir una lámina de acero recubierta con zinc o aleación de (...TRUNCATED) | "Un método para producir una lámina de acero recubierta con zinc o aleación de zinc con una resis(...TRUNCATED) | es | es | assertion_verification | assertion_verification | gpt-5.6-luna | MX-2019015511-A_es | MX-2019015511-A_es | MX-2019015511-A_es | "Un método para producir una lámina de acero recubierta con zinc o aleación de zinc con una resis(...TRUNCATED) | es | "Un método para producir una lámina de acero recubierta con zinc o aleación de zinc con una resis(...TRUNCATED) | evidence | exact | "Un método para producir una lámina de acero recubierta con zinc o aleación de zinc con una resis(...TRUNCATED) | "Un método para producir una lámina de acero recubierta con zinc o aleación de zinc con una resis(...TRUNCATED) | exact | clear | "{\"anchor\": \"método para producir una lámina de acero recubierta con zinc o aleación de zinc\"(...TRUNCATED) | "{\"anchor\": \"método para producir una lámina de acero recubierta con zinc o aleación de zinc\"(...TRUNCATED) | "{\"file\": \"data/chemistry/ai4chem_abstract_pairs/qac/chemistry_google_patents_model_comparison_ge(...TRUNCATED) | null | false | null | false | null | false | false | null | false | 1 | 0 | 2,242 | 0 | [] | [
"MX-2019015511-A_es"
] | [] | 11 | 20 | 31 | {"en":[{"source_unit_id":"MX-2019015511-A_en","language":null,"text":"soaking the sheet at T2, then (...TRUNCATED) | {"en":[{"source_unit_id":"MX-2019015511-A_en","anchor_id":"a_e9a3a61c550d42a306f427df6fed30101a00296(...TRUNCATED) | eligible | cross_language_evidence_terra_v1 | ["soaking the sheet at T2, then cooling the sheet at a rate comprised between 10 and 400°C/s, then (...TRUNCATED) | [] | ["Un método para producir una lámina de acero recubierta con zinc o aleación de zinc con una resi(...TRUNCATED) | [] | [] | |||||||
q_1e6b2c946a72c20c78192a544d485fce99c70527e1ca2ca1d12893bfba5c6c84 | chemistry | "Dans le traitement thermique en four d’un matériau pulvérulent destiné notamment à la product(...TRUNCATED) | "Le coefficient Ζ de remplissage de la section transversale du tambour avec le matériau pulvérule(...TRUNCATED) | fr | fr | lookup | lookup | gpt-5.6-luna | WO-9738948-A1_fr | WO-9738948-A1_fr | WO-9738948-A1_fr | "Le coefficient Ζ de remplissage de la section transversale du tambour avec le matériau pulvérule(...TRUNCATED) | fr | "Le coefficient Ζ de remplissage de la section transversale du tambour avec le matériau pulvérule(...TRUNCATED) | evidence | exact | "Procédé pour le traitement thermique d'un matériau dispersé ou pulvérulent, dans lequel on pr(...TRUNCATED) | "Procédé pour le traitement thermique d'un matériau dispersé ou pulvérulent, dans lequel on pr(...TRUNCATED) | exact | clear | "{\"anchor\": \"coefficient Ζ de remplissage de la section transversale du tambour avec le matéria(...TRUNCATED) | "{\"anchor\": \"coefficient Ζ de remplissage de la section transversale du tambour avec le matéria(...TRUNCATED) | "{\"file\": \"data/chemistry/ai4chem_abstract_pairs/qac/chemistry_google_patents_model_comparison_ge(...TRUNCATED) | null | false | null | false | null | false | false | null | false | 1 | 580 | 1,197 | 0 | [] | [
"WO-9738948-A1_fr"
] | [] | 12 | 20 | 32 | {"en":[],"de":[],"es":[{"source_unit_id":"WO-9738948-A1_es","language":null,"text":"El coeficiente (...TRUNCATED) | {"en":[],"de":[],"es":[{"source_unit_id":"WO-9738948-A1_es","anchor_id":"a_584e688e5ef3dec05d3fb0338(...TRUNCATED) | eligible | cross_language_evidence_terra_v1 | [] | [] | ["El coeficiente Ζ de llenado de la sección transversal del tambor por el material disperso se eli(...TRUNCATED) | ["Le coefficient Ζ de remplissage de la section transversale du tambour avec le matériau pulvérul(...TRUNCATED) | [] | |||||||
q_aa95f01681be391ea84446fa7a5971d69e2998f8d21b38b7114b849a25aa5d5e | chemistry | "What sustainable-material packaging architecture can house water-soluble detergent capsules while p(...TRUNCATED) | "Packaging for water-soluble detergent capsules comprising a body (10) materialized by a sheet of di(...TRUNCATED) | en | en | constraint_search | constraint_search | gpt-5.6-luna | ES-1310953-U_en | ES-1310953-U_en | ES-1310953-U_en | "Packaging for water-soluble detergent capsules comprising a body (10) materialized by a sheet of di(...TRUNCATED) | en | "Packaging for water-soluble detergent capsules comprising a body (10) materialized by a sheet of di(...TRUNCATED) | evidence | exact | "Packaging for water-soluble detergent capsules comprising a body (10) materialized by a sheet of di(...TRUNCATED) | "Packaging for water-soluble detergent capsules comprising a body (10) materialized by a sheet of di(...TRUNCATED) | exact | clear | "{\"anchor\": \"water-soluble detergent capsules\", \"assertion\": \"\", \"assertion_status\": \"\",(...TRUNCATED) | "{\"anchor\": \"water-soluble detergent capsules\", \"answer\": \"Packaging for water-soluble deterg(...TRUNCATED) | "{\"file\": \"data/chemistry/ai4chem_abstract_pairs/qac/chemistry_google_patents_model_comparison_ge(...TRUNCATED) | null | false | null | false | null | false | false | null | false | 1 | 0 | 2,024 | 0 | [] | [
"ES-1310953-U_en"
] | [] | 12 | 20 | 32 | {"en":[{"source_unit_id":"ES-1310953-U_en","language":"en","text":"Packaging for water-soluble deter(...TRUNCATED) | {"en":[{"source_unit_id":"ES-1310953-U_en","anchor_id":"a_b3700a4f180d47aff4c42583884653433095922a20(...TRUNCATED) | eligible | cross_language_evidence_terra_v1 | ["Packaging for water-soluble detergent capsules comprising a body (10) materialized by a sheet of d(...TRUNCATED) | [] | ["Embalaje para cápsulas hidrosolubles de detergente que comprende un cuerpo (10) materializado med(...TRUNCATED) | [] | [] |
Multilingual generated QAs and source corpora
Multilingual supporting evidence
The qas configuration now includes native nested evidence_all_languages and
evidence_alignment_status fields with the five keys en, de, es, fr, and
zh. Each language contains a list of span/status objects; an unavailable language
has an empty list. Original questions, answers, metadata, and corpus records are
preserved. Arabic and Russian corpus versions remain available where previously
published; this alignment run did not create evidence in those languages.
For easy reading, evidence_en, evidence_de, evidence_es, evidence_fr, and
evidence_zh contain lists of the exact passage strings. A corpus-specific
readable CSV contains these fields alongside
questions and answers. In its readable language columns, one span is plain text,
no span is an empty cell, and multiple spans use a JSON list. Native Parquet
columns always remain lists. No span strings are joined, translated, or normalized.
Original supporting text is marked source_exact. Generated spans are literal
matches in the linked target document and remain pending_review: exact quotation
does not establish semantic equivalence or independent human review. The
language-specific status lists retain unsuccessful/uncertain alignments and their
provenance. evidence_alignment_eligibility explains excluded QAs (for example,
missing exact original support or a quarantined language label); such questions
remain in the dataset without invented evidence. The contract is
cross_language_evidence_terra_v1. Legacy evidence/evidence_language columns and the separate
evidence configuration keep their previous interpretation.
from datasets import load_dataset
qas = load_dataset("MehdiAstaraki/chemistry-generated-qa", "qas", split="train")
row = next(row for row in qas if row["evidence_all_languages"]["en"])
print(row["question"])
print(row["evidence_all_languages"]["en"][0]["text"])
print(row["evidence_en"])
This update adds supporting passages only. It creates no retrieval chunks or new
relevance judgments, and does not change source_qrels.
Contains documents associated with the published questions and their available translations. This QA release does not include the complete retrieval haystack.
All supplied generator candidates are retained, including low-scoring and unmatched evidence.
The train split is a storage convention; no leakage-safe evaluation split has been assigned.
Before splitting, group questions from the same article/act, UN document, or patent and its
translation partners to avoid source and generator leakage.
Configurations
qas: 1,950 rowsevidence: 1,950 rowssource_qrels: 4,033 rowscorpus: 409 rowsqas: questions, answers, raw evidence, persona/mode, model, scores, source IDs and involvement.document_textembeds the complete primary source unit; additional involved units are linked throughinvolved_source_unit_idstocorpus.metadata_jsonpreserves the complete input row, including persona-specific fields, prompts, grading responses, routing decisions and generation references.provenance_jsonidentifies the input file and row/task. CSV metadata preserves its original string types.evidence: canonical supporting text: explicitevidencewhere present, otherwiseanswer.origindistinguishes the two.startandendrefer to the original corpus unit'stext, in Unicode code points, end-exclusive; only the first exact match receives offsets. Matching checks only presence (exact or whitespace-normalized), not factual entailment. Support is checked against the primary source, not every involved/translated document.corpus:_id, text, language, source/parent IDs, unit type and original metadata. EUR-Lex units are full articles (or explicitly involved annexes); patent units are title + abstract; UN units are entire documents joined from the original aligned lines. UN block IDs/ranges survive in QA metadata only. EUR-Lex duplicate ELI/language records use the last occurrence, matching the generation loader. Source text and patent markup are retained.source_qrels: positive source-unit associations derived from generation provenance, plus existing language versions of each legal unit / directly accepted chemistry translation partners. They are not manually judged relevance or chunk-level qrels.score=1indicates an association; absent judgments do not establish irrelevance. Supplied contextual references alone do not create positives. Chemistry partners are not expanded transitively.
involved_source_unit_ids includes the primary source and explicitly involved EUR-Lex units;
involved_article_ids includes article ELIs only. multi_article is true when multiple articles
are resolved or the generator declared it. multi_article_declared retains that declaration;
multi_article_conflict identifies a disagreement with the resolved article count. cross_act
means involvement across acts; multi_source_unit also covers an article plus an annex.
A translation into another language does not count as another involved article.
UN and chemistry have no article-involvement annotation, so their multi_article is false
and multi_article_declared is null; supplied UN references are retained only as metadata.
These source units have not yet been chunked. Create retrieval chunks with a pinned tokenizer (e.g. BAAI/bge-m3), preserve parent IDs and character ranges, and align evidence to those chunks. Do not mark every chunk of a source document relevant. Unmatched or translated evidence needs separate alignment/review before it can establish chunk-level judgments.
manifest.json records export inputs and SHA-256 hashes; report.json records coverage,
models, personas, evidence matching and multi-article statistics. No upstream license is
assigned to generated material by this exporter.
Attribution and source terms
BASF-AI AI4Chem abstract pairs
- Source dataset: BASF-AI/ai4chem-clir-google-patents-within-document-abstract-pairs, maintained by BASF-AI. The upstream dataset contains pairs of cleaned abstracts from the same Google Patents publication.
- Selection: This derived corpus retains pairs with
pair_ok=trueandjudge_verdictequal toexactorhigh, with both endpoints in English, German, French, Spanish or Chinese. Retrieval positives follow the accepted direct pair links. - Provenance: The corpus preserves the upstream dataset revision, corpus and group identifiers, accepted pair identifiers and paired document identifiers. Questions, answers and grading are generated by this benchmark pipeline.
- Terms: The upstream dataset card does not establish a verified license for these paired records or their underlying patent text. Consult the upstream dataset and the applicable source terms; this notice does not assign a license or import a historical BigQuery license claim.
- No endorsement: This benchmark is independent of BASF-AI and the providers of the underlying patent publications.
- Downloads last month
- 151